New 7-gene test strategy*could improve life expectancy for women at risk of hereditar
 

Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research, announced today the publication of new research indicating that testing for variants in 7 cancer-associated genes (versus the usual process of testing in just 2 genes) followed by risk-reduction management could cost-effectively improve life expectancy for women at risk of hereditary breast cancer.

More...